Latest literature | Zhongnan Medical Journal Press

Home Literature Latest literature

Latest literature

Visual analysis of research hotspots and trends on immunomodulatory effects of Tripterygium Wilfordii Hook.f.

Published on Chinese Journal of Pharmacoepidemiology 2026,35(7):818-826.
2456 times 793 times

XIAN Zicheng CHEN Chao JIANG Mengting ZHOU Yinmin LI Xue YANG Ming

Tripterygium wilfordii Hook.f. Immune regulation Bibliometrics Citespace Visual analysis
Details
Meta-analysis of efficacy and safety of pertuzumab biosimilars versus original drug in the treatment of patients with HER2-positive breast cancer

Published on Chinese Journal of Pharmacoepidemiology 2026,35(7):810-817.
2639 times 824 times

GU Shilong ZHANG Wenjing GUO Hao

Pertuzumab Biosimilars Original drug HER2 Breast cancer Efficacy Safety Meta-analysis
Details
Rapid health technology assessment of donanemab in the treatment of Alzheimer's disease

Published on Chinese Journal of Pharmacoepidemiology 2026,35(7):800-809.
2901 times 968 times

FAN Liming DENG Tiantian LAN Haiyue DONG Yafen QIU Yan WANG Jian

Donanemab Alzheimer's disease Efficacy Safety Cost-effectiveness Rapid health technology assessment
Details
Signal analysis of adverse events associated with pertuzumab-trastuzumab based on the FAERS database

Published on Chinese Journal of Pharmacoepidemiology 2026,35(7):792-799.
2459 times 794 times

ZHANG Juan ZHU Haizhou ZHANG Xue GUO Kaixing

Pertuzumab-trastuzumab FAERS database Adverse drug events Signal mining Reporting odds ratio Pharmacovigilance
Details
Signal mining and analysis of adverse events of mirikizumab based on FAERS and EudraVigilance databases

Published on Chinese Journal of Pharmacoepidemiology 2026,35(7):783-791.
2363 times 830 times

YAN Xu SUN Kun JI Zhaoshuai NIE Guangmeng

Mirikizumab Crohn's disease Ulcerative colitis FAERS EudraVigilance Signal mining
Details
Mining and analysis of adverse event signals for three novel lipoglycopeptide antibiotics based on the FAERS and WHO-VigiAccess database

Published on Chinese Journal of Pharmacoepidemiology 2026,35(7):773-782.
2348 times 908 times

ZHANG Yao HU Zhansong ZHAO Xiaoyun CHEN Lijuan

Lipoglycopeptide antibiotics Adverse events FAERS WHO-VigiAccess Signal mining
Details
Clinical efficacy of Tianqi Jiangtang capsule combined with empagliflozin in newly diagnosed type 2 diabetes mellitus patients

Published on Chinese Journal of Pharmacoepidemiology 2026,35(7):765-772.
2826 times 949 times

SHI Jin PEI Zijuan ZHANG Dan CHEN Dan WANG Dandan ZHANG Li SHI Kaiyue WANG Dan XIE Muya YAN Ying

Type 2 diabetes Tianqi Jiangtang capsules Empagliflozin Blood sugar Insulin
Details
Impact of enhanced recovery after surgery intervention on postoperative recovery in patients undergoing colorectal cancer surgery treated with Bacillus licheniformis

Published on Chinese Journal of Pharmacoepidemiology 2026,35(7):757-764.
2457 times 830 times

WANG Feifei LU Xiaoyue XU Dafang

Enhanced recovery after surgery Bacillus licheniformis Colorectal cancer Postoperative recovery time Perioperative nursing
Details
Long-term efficacy, safety, and risk stratification for hyperkalemia associated with finerenone in patients with diabetic kidney disease

Published on Chinese Journal of Pharmacoepidemiology 2026,35(7):747-756.
2807 times 960 times

XIE Yang LI Lin HAN Wenxia

Finerenone Diabetic kidney disease Real-world study Linear mixed model Urinary albumin-to-creatinine ratio Risk stratification
Details
Efficacy of popliteal sciatic nerve block versus total intravenous anesthesia in diabetic foot surgery and analysis of influencing factors for wound healing

Published on Chinese Journal of Pharmacoepidemiology 2026,35(7):738-746.
2489 times 781 times

YANG Yue PENG Junbo LU Xinlei

Diabetic foot Popliteal sciatic nerve block Intravenous anesthesia Wound healing Hemodynamics Risk factors
Details
Influencing factors for unfavorable outcomes of doxycycline therapy in children with macrolide-resistant Mycoplasma pneumoniae pneumonia

Published on Chinese Journal of Pharmacoepidemiology 2026,35(7):732-737.
3002 times 943 times

GAO Yufeng WU Qiong LIN Zhi

Doxycycline Children Macrolide-resistant Mycoplasma pneumoniae pneumonia Clinical outcome Risk factors
Details
Guide on Methodological Standards in Pharmacoepidemiology in China (2nd edition) and their series interpretation (19): tool systems and methodological paradigms for common data model-based data analysis

Published on Chinese Journal of Pharmacoepidemiology 2026,35(7):721-731.
2651 times 875 times

WU Yunxiao NIE Xiaolu ZHENG Yongqi WANG Conghui WU Jiarui SUN Yexiang SONG Haibo ZHAN Siyan SUN Feng

Pharmacoepidemiology Methodology Guideline Common data model Real world evidence
Details
Problems and countermeasures of scientific research drug dispensing management in medical instisutions

Published on Frontiers in Pharmaceutical Sciences 2026,30(6):1074-1080.
3489 times 838 times

SHAO Xiyue LI Rongqi ZHOU Ziye ZHANG Xiuhua

Medical Institutions Basic research Clinical research Scientific drugs Dispensing and management Reflections
Details
Research progress on chemical constituents, pharmacological effects and quality control of Swertia patens Burk.

Published on Frontiers in Pharmaceutical Sciences 2026,30(6):1066-1073.
3054 times 822 times

TIAN Shuxing ZI Fayun YANG Qiaoyan SHI Xiufang ZOU Lan WANG Jimei ZHANG Pan

Swertia patens Burk. Chemical composition Pharmacological effects Quality control Yi medicine
Details
Research status of quality control for medicinal plants of the Callerya

Published on Frontiers in Pharmaceutical Sciences 2026,30(6):1057-1065.
3191 times 827 times

XIAO Ling WANG Yilan

Callerya Callerya dielsiana Callerya nitidavar. hirsutissima Callerya speciosa Quality standard Research progress
Details
Analysis of control strategies for nitrosamine drug substance-related impurities

Published on Frontiers in Pharmaceutical Sciences 2026,30(6):1047-1056.
3072 times 713 times

LI Hao QI Qiancheng ZHANG Shuai SUN Caixia

Nitrosamine drug substance-related impurities Control strategies Risk assessment Limit determination Analytical methods Elimination strategies
Details
Research progress on active ingredients of traditional Chinese medicine in preventing and treating ischemic heart disease based on mitochondrial dynamics regulation

Published on Frontiers in Pharmaceutical Sciences 2026,30(6):1036-1046.
3443 times 754 times

ZHOU Miao WEI Lei LI Maxizi TIAN Silan WANG Yinmei

Ischemic heart disease Mitochondrial dynamics Active ingredients of traditional Chinese medicine Mitophagy Myocardial ischemia-reperfusion injury
Details
Visual analysis of research status on drought stress in medicinal plants based on bibliometrics

Published on Frontiers in Pharmaceutical Sciences 2026,30(6):1025-1035.
2839 times 680 times

YE Qiuju YIN Haibo WANG Dan LU Yao SUN Jie WU Ying DU Junnan

Medicinal plants Drought stress Bibliometrics CiteSpace VOSviewer Cluster analysis
Details
Efficacy and safety of antihypertensive drugs combined with folic acid in treating hypertension with hyperhomocysteinemia: a systematic review and Meta-analysis

Published on Frontiers in Pharmaceutical Sciences 2026,30(6):1010-1024.
3359 times 806 times

LONG Zhiping WANG Changwen SUN Fanfan XU Shibo YAN Junzhen ZENG Cheng

Antihypertensive drugs Folic acid Hypertension Hyperhomocysteinemia Meta-analysis Randomized controlled trials
Details
Research on hierarchical early warning of drug shortages based on probability prediction and interval estimation

Published on Frontiers in Pharmaceutical Sciences 2026,30(6):1001-1009.
3261 times 674 times

FENG Yuhan JIANG Tingyuan JING Fuhao TANG Pengzhan PANG Zhonghua

Drug shortage Demand forecasting Hybrid model Variational mode decomposition Newton-Raphson-based optimizer Least squares support vector machine DeepAR Long short-term memory network Tiered early warning
Details